Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream ...

Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...

In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company's commitment to ...

"Every cancer has a flower—my cancer is a sunflower. The sunflower is the only flower that can grow 6 feet tall. It is resilient," the mom said.

Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy in India. This ...

Researchers compared QOL and other outcomes between patients with endometrial cancer who took short-course adjuvant VCB and ...

Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision ...

Four oncologists from the Sarah Cannon Research Institute in Tennessee shared with Fox News Digital what they see as the most ...

A Wakefield dad-to-be who received a devastating cancer diagnosis has thanked the community for their incredible support.

( MENAFN - Baystreet) Issued on behalf of Oncolytics Biotech Inc.

Sino Biopharmaceutical (HK:1177) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...